Option Chain

Jade Biosciences Inc

JBIONASDAQ · USD

14.73USD+0.02 (+0.14%)

2110

Jade Biosciences Inc (JBIO) Option Chain

As of September 23, 2026, Jade Biosciences Inc is trading at $14.73, a +0.14% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 101.5%. IV Rank is 17%.

Tracking the JBIO option chain helps you see every strike and expiry on Jade Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Jade Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of JBIO options activity at a glance. Use our scanner to monitor the JBIO option chain in real time and filter for the JBIO options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For JBIO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the JBIO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where JBIO stock options are being actively traded and where they are not.

Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA) nephropathy. JADE-001 is anticipated to enter clinical trials in the second half of 2025, with initial data expected in the first half of 2026. The company's pipeline also includes two preclinical antibody programs, JADE-002 and JADE-003.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Jade Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen JBIO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of JBIO stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile29.76% Subdued
Market cap (M$)936
52 weeks high-47.46%
52 weeks low94.06%
Analyst recommendationStrong Buy
1.00
Target price$49.89
238.70% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-12
P/E—
Future P/E—
EPS (ttm)-2.61
EPS growth next 5 years3.74%

As of September 23, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
29.93	0	0	0.92	2.23	1.40	4.90	12.50	-15.02	—	4.10	0.00	4.10	0	0	70.07
57.69	0	2	1.15	0.00	0.60	1.70	15.00	+1.97	—	1.50	0.27	1.23	0	1	42.31
78.90	461	0	1.50	0.00	—	1.50	17.50	+18.97	0.50	4.90	2.77	-0.07	0	0	21.10
90.83	0	0	0.95	0.00	—	0.95	20.00	+35.96	3.00	7.30	5.27	-0.12	0	0	9.17
96.37	0	0	0.75	0.00	—	0.75	22.50	+52.96	5.50	9.10	7.77	-0.47	0	0	3.63

As of September 23, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place